CA2839125C - Method of measuring blood coagulation time to detect lupus anticoagulants - Google Patents

Method of measuring blood coagulation time to detect lupus anticoagulants Download PDF

Info

Publication number
CA2839125C
CA2839125C CA2839125A CA2839125A CA2839125C CA 2839125 C CA2839125 C CA 2839125C CA 2839125 A CA2839125 A CA 2839125A CA 2839125 A CA2839125 A CA 2839125A CA 2839125 C CA2839125 C CA 2839125C
Authority
CA
Canada
Prior art keywords
blood coagulation
reagent
time
measurement
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2839125A
Other languages
English (en)
French (fr)
Other versions
CA2839125A1 (en
Inventor
Masahiro IEKO
Chizuru Morikawa
Keiko HATTORI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHOOL JURIDICAL PERSON HIGASHI-NIPPON-GAKUEN
Sekisui Medical Co Ltd
Original Assignee
SCHOOL JURIDICAL PERSON HIGASHI-NIPPON-GAKUEN
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHOOL JURIDICAL PERSON HIGASHI-NIPPON-GAKUEN, Sekisui Medical Co Ltd filed Critical SCHOOL JURIDICAL PERSON HIGASHI-NIPPON-GAKUEN
Publication of CA2839125A1 publication Critical patent/CA2839125A1/en
Application granted granted Critical
Publication of CA2839125C publication Critical patent/CA2839125C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2839125A 2011-06-17 2012-06-15 Method of measuring blood coagulation time to detect lupus anticoagulants Active CA2839125C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011-135174 2011-06-17
JP2011135174 2011-06-17
PCT/JP2012/065434 WO2012173260A1 (ja) 2011-06-17 2012-06-15 ループスアンチコアグラント検出用血液凝固時間の測定方法

Publications (2)

Publication Number Publication Date
CA2839125A1 CA2839125A1 (en) 2012-12-20
CA2839125C true CA2839125C (en) 2019-08-06

Family

ID=47357238

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2839125A Active CA2839125C (en) 2011-06-17 2012-06-15 Method of measuring blood coagulation time to detect lupus anticoagulants

Country Status (8)

Country Link
US (1) US9970046B2 (enExample)
EP (1) EP2722675B1 (enExample)
JP (2) JP5640189B2 (enExample)
KR (1) KR102001662B1 (enExample)
CN (1) CN103688177B (enExample)
CA (1) CA2839125C (enExample)
ES (1) ES2613723T3 (enExample)
WO (1) WO2012173260A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4425145A3 (en) * 2015-03-20 2025-01-08 Hitachi High-Tech Corporation Automatic analysis device and automatic analysis method
JP6871673B2 (ja) * 2015-03-31 2021-05-12 学校法人東日本学園 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置
JP6499488B2 (ja) * 2015-03-31 2019-04-10 学校法人東日本学園 凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット
JP6864008B2 (ja) 2016-04-25 2021-04-21 インストゥルメンテーション ラボラトリー カンパニー 抗リン脂質抗体症候群に関連するループス抗凝固因子(la)を特定するための方法およびキット
JP6837851B2 (ja) * 2017-01-31 2021-03-03 シスメックス株式会社 血液検体の判定方法、並びに血液検体の分析のための装置及びコンピュータプログラム
CN108761104A (zh) * 2018-05-21 2018-11-06 深圳优迪生物技术有限公司 凝血激活剂及其应用
CN109709344A (zh) * 2018-12-29 2019-05-03 贵州金玖生物技术有限公司 一种活化凝血检测试剂、其制备方法及其应用
EP3919913A4 (en) * 2019-01-31 2022-11-09 Sekisui Medical Co., Ltd. PROCEDURE FOR ANALYZING BLOOD COAGULATION PROPERTIES OF A BLOOD SAMPLE
CN112557665B (zh) * 2020-11-10 2023-06-09 北京美创新跃医疗器械有限公司 一种狼疮抗凝物的确认试剂及其制备方法
CN114778858A (zh) * 2022-06-23 2022-07-22 深圳市帝迈生物技术有限公司 一种狼疮抗凝物检测试剂盒

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461969A1 (de) 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
JPH0650999B2 (ja) 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
US4877741A (en) * 1988-10-24 1989-10-31 The United States Of America As Represented By The Secretary Of The Air Force Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant
EP0482088B1 (en) 1989-07-20 1999-03-31 Analytical Control Systems, Inc. Improved stable coagulation controls
JPH06324048A (ja) * 1993-05-15 1994-11-25 Shimizu Seiyaku Kk 血液凝固能検査用試薬及び血液凝固能の検査方法
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
WO2001048486A1 (en) 1999-12-24 2001-07-05 International Reagents Corporation Means of stabilizing compositions and reagents
CN1126758C (zh) 2001-08-16 2003-11-05 四川高维系统工程技术有限公司 凝血因子ⅸ复合物的制备方法
KR101006070B1 (ko) 2001-12-21 2011-01-06 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ⅶ 폴리펩티드의 액체 조성물
EP3103869A1 (en) 2003-03-18 2016-12-14 Novo Nordisk Health Care AG Method for the production of factor vii polypeptides
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
EP1920068A4 (en) 2005-07-28 2008-08-13 American Diagnostica Inc LUPIC ANTICOAGULANT TEST
CN101221189B (zh) * 2007-01-12 2012-08-15 上海太阳生物技术有限公司 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒
US20100303786A1 (en) 2007-11-22 2010-12-02 Novo Nordisk Health Care Ag Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing Compounds
WO2009082648A1 (en) 2007-12-21 2009-07-02 Inspiration Biopharmaceuticals, Inc. Stabilized factor ix formulations containing trehalose
CA2727351C (en) 2008-06-18 2017-10-31 Sekisui Medical Co., Ltd. Method for determining cause of the prolongation of blood coagulation time
US8329871B2 (en) 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII

Also Published As

Publication number Publication date
ES2613723T3 (es) 2017-05-25
KR20140033422A (ko) 2014-03-18
KR102001662B1 (ko) 2019-10-01
US9970046B2 (en) 2018-05-15
JP5640189B2 (ja) 2014-12-17
EP2722675B1 (en) 2017-01-11
US20140127726A1 (en) 2014-05-08
JP6025105B2 (ja) 2016-11-16
CN103688177A (zh) 2014-03-26
EP2722675A4 (en) 2015-02-25
WO2012173260A1 (ja) 2012-12-20
JP2014209134A (ja) 2014-11-06
CN103688177B (zh) 2017-07-04
EP2722675A1 (en) 2014-04-23
CA2839125A1 (en) 2012-12-20
JPWO2012173260A1 (ja) 2015-02-23

Similar Documents

Publication Publication Date Title
US9970046B2 (en) Method of measuring blood coagulation time to detect lupus anticoagulants
US8357539B2 (en) Activated partial thromboplastin time measuring reagent, activated partial thromboplastin time measuring method, and determination method for determining presence or absence of blood coagulation inhibitor
US8557592B2 (en) Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant
US8759108B2 (en) Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant
US20140295470A1 (en) Method and reagent kit for measuring activated partial thromboplastin time
US5766869A (en) Factor V ratio blood test for susceptibility to thromboembolism
CA2839117C (en) Method for detecting lupus anticoagulants
CN112557665B (zh) 一种狼疮抗凝物的确认试剂及其制备方法
US7727736B2 (en) Soluble phospholipids for use in clotting factor assays
ES3044920T3 (en) Method for determining fibrinogen

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170526

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250430

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250430

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260428

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260428